News
5th Circuit Court Rules Federal Ban on Cannabis Users Owning Guns Unconstitutional
LOS ANGELES- The 5th U.S. Circuit Court of Appeals has declared that prosecuting a cannabis user for gun ownership under federal law is unconstitutional, marking a significant ruling that challenges longstanding federal restrictions. The decision stems from the case of Paola Connelly, a Texas resident who admitted to occasional cannabis use and was subsequently charged ...
Nebraska Certifies Medical Cannabis Ballot Measures for November Election
LOS ANGELES- The Nebraska Secretary of State has officially certified two ballot measures aimed at legalizing medical cannabis and establishing a regulated cannabis industry in the state. The measures, which will appear on the November election ballot, represent the third attempt by advocates to bring medical cannabis reform to Nebraska voters. The campaign, led by ...
Cannabis Industry Reacts to Trump’s Endorsement of Florida Legalization Initiative
LOS ANGELES- Former President Donald Trump's recent endorsement of Florida's Amendment 3, which seeks to legalize recreational cannabis in the state, has sparked immediate responses from key figures in the cannabis industry. The proposed constitutional amendment will appear on the November ballot and requires 60% voter approval to pass. Industry Leaders Respond Kim Rivers, CEO ...
Week’s In Review: Curaleaf Reports Revenue Growth in Q2 2024; DEA’s Postponement of Cannabis Rescheduling Raises Uncertainty for Industry; Pakistan Enters Global Hemp Market with Plans for 2025 Cultivation
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights 1#Curaleaf Reports Revenue Growth in Q2 2024: Curaleaf Holdings, Inc. reported a net loss ...
DEA’s Postponement of Cannabis Rescheduling Raises Uncertainty for Industry
LOS ANGELES- The Drug Enforcement Administration (DEA) has delayed the decision to reschedule cannabis under the Controlled Substances Act (CSA) until after the 2024 presidential election, creating significant uncertainty in the ongoing cannabis reform debate. Cannabis has remained a Schedule I drug for over 50 years, a classification indicating high abuse potential and no accepted ...
Red Light Holland Reports Q1 2025
LOS ANGELES- Red Light Holland, an Ontario-based corporation specializing in the production, growth, and sale of functional mushrooms, mushroom home grow kits, and psilocybin truffles, has announced its financial and operational results for the three months ending June 30, 2024. All figures are reported in Canadian dollars. In the first quarter of 2025, Red Light ...
Pakistan Enters Global Hemp Market with Plans for 2025 Cultivation
LOS ANGELES- Pakistan is set to join the global hemp market by allowing commercial cultivation of hemp beginning in January 2025. This strategic move is aimed at enhancing the country’s economy through increased foreign exchange earnings and the creation of new economic opportunities. The Pakistani government sees immense potential in the hemp industry, which has ...
Curaleaf Reports Revenue Growth in Q2 2024
LOS ANGELES- Curaleaf Holdings, Inc. reported a net loss of $49.8 million for Q2 2024, bringing its year-to-date losses to over $100 million. Despite these losses, the company achieved a 2% increase in revenue, reaching $342.2 million, up from $335.5 million in the same quarter last year. For the first half of 2024, revenue totaled ...
Awakn Life Sciences Advances Phase 3 Trial for Alcohol Use Disorder Treatment
LOS ANGELES- Awakn Life Sciences Corp. announced the screening of its first patient for the Phase 3 trial of AWKN-001, a new treatment targeting severe Alcohol Use Disorder (AUD). The trial, known as MORE-KARE, represents a significant milestone in assessing the effectiveness of AWKN-001. AWKN-001 combines intravenous ketamine, an N-methyl-D-aspartate receptor modulator, with structured psycho-social ...
The Cannabist Reports Mixed Q2 2024 Results
LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop from last year’s $129 million. Despite the decline, revenue surpassed analysts’ expectations of $124 million. Net losses were reduced to ...
MindMed Launches $75 Million Public Offering to Fund Psychedelic Research
LOS ANGELES- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) announced a public offering aimed at raising $75 million through the sale of approximately 9.2 million shares at $7 each. The company is also offering around 1.4 million shares at a slightly discounted price of $6.99 to select investors. The offering is expected to close on August ...
Ayr Wellness Reports Revenue Increase in Q2 2024
LOS ANGELES- Ayr Wellness Inc. posted a slight revenue increase for Q2 2024, reporting earnings of $117 million, a 0.5% improvement compared to the same quarter last year but a 0.6% decline from Q1 2024. The results fell short of analysts' projections, which anticipated revenue of $119 million. The company attributed the decline in performance ...
Verano Holdings Reports Mixed Q2 2024 Results
LOS ANGELES- Verano Holdings Corp. reported mixed financial results for Q2 2024, with revenue reaching $222 million, reflecting a 0.5% increase from the previous quarter but a 5% decline year-over-year. The revenue aligned with the company’s guidance for flat to low single-digit growth but fell slightly short of analysts’ expectations, which projected $224.36 million. The ...
Ascend Wellness Reports Revenue Growth in Q2 2024
LOS ANGELES- Ascend Wellness Holdings, Inc. delivered a mixed performance for Q2 2024, reflecting both revenue gains and profitability pressures. The company reported a 15% year-over-year increase in revenue, reaching $141.5 million. Despite this growth, profitability declined significantly, with a net loss of $21.8 million compared to a net income of $800,000 in the same ...
MindMed Launches $75 Million Public Offering to Fund Psychedelic Research
LOS ANGELES- Mind Medicine (MindMed) Inc. announced a public offering aimed at raising $75 million through the sale of approximately 9.2 million shares at $7 each. The company is also offering around 1.4 million shares at a slightly discounted price of $6.99 to select investors. The offering is expected to close on August 12, with ...
Green Thumb Industries Reports Strong Q2 2024 Performance
LOS ANGELES- Green Thumb Industries Inc. a Chicago-based cannabis company, posted solid second-quarter results for 2024, with revenue climbing 11% year-over-year to $280 million, exceeding analyst forecasts of $277.36 million. The company’s net income rose to $20.7 million, up from $13.4 million in the same period last year. Adjusted EBITDA reached $93.8 million, accounting for ...
Week’s In Review: TerrAscend Corp. Announces $10 Million Share Buyback Program; Bipartisan Lawmakers Push for MDMA Therapy for PTSD as FDA Decision Looms; Verano Acquires Cannabist Company’s Operations in Arizona and Virginia for $105 Million
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights #1 TerrAscend Corp. Announces $10 Million Share Buyback Program: TerrAscend Corp., a prominent North ...
atai Life Sciences Reports Q2 2024 Financial Results
LOS ANGELES- atai Life Sciences, a biopharmaceutical company focused on transforming mental health treatment, announced its financial results for the second quarter of 2024 along with updates on its clinical pipeline. The company highlighted significant progress in advancing its VLS-01 and EMP-01 programs, which target treatment-resistant depression (TRD) and social anxiety disorder (SAD), respectively. Dr. ...
TerrAscend Corp. Announces $10 Million Share Buyback Program
LOS ANGELES- TerrAscend Corp., a prominent North American cannabis company, has initiated a normal course issuer bid (NCIB) to repurchase up to $10 million of its common shares over the next 12 months. The program, which begins on August 22, 2024, was approved by the company’s board of directors and reflects TerrAscend’s confidence in its ...
Sumitomo Mitsui Trust Holdings Reduces Stake in COMPASS Pathways by 11.8% in Q2
LOS ANGELES- Sumitomo Mitsui Trust Holdings Inc. has reduced its stake in COMPASS Pathways plc (NASDAQ: CMPS) by 11.8% during the second quarter, according to a recent filing with the Securities and Exchange Commission (SEC). The company sold 38,745 shares, bringing its total holdings to 288,459 shares valued at $1.74 million as of the most ...
Out-of-State Applicants Dominate Minnesota’s Early Cannabis License Applications
LOS ANGELES- Minnesota's newly established cannabis market is attracting significant interest from out-of-state applicants, according to recent data from the Office of Cannabis Management (OCM). Of the 1,817 pre-applications submitted this summer for various cannabis licenses, over half originated from individuals residing outside Minnesota. The state's cannabis law does not mandate residency, allowing out-of-state applicants ...
Bipartisan Lawmakers Push for MDMA Therapy for PTSD as FDA Decision Looms
LOS ANGELES- In a rare show of bipartisanship, 80 members of Congress have united to urge President Joe Biden and the FDA to prioritize research on MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD). The initiative, which seeks to fast-track access to new treatment options, is driven by a rising veteran suicide crisis and the ...
Morocco Pardons 5,000 for Illegal Cannabis Cultivation in Push Toward Legal Market
LOS ANGELES- Morocco’s King Mohammed VI has pardoned nearly 5,000 individuals previously convicted or wanted for illegal cannabis cultivation, a move aimed at facilitating the transition to the legal cannabis market. The royal pardon is intended to incentivize farmers in Morocco’s traditional cannabis-growing regions to engage in licensed cultivation, which has been legal for medical ...
Willow Biosciences Posts Record Revenue in Q2
LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. Despite this growth, the company posted a net loss of $1.7 million as it continues to invest in research and ...
MindBio Reports Sustained Antidepressant Effects from Microdosing LSD in Phase 2A Depression Trials
LOS ANGELES- MindBio Therapeutics Corp. a Vancouver-based biopharmaceutical company, has announced promising durability data from its Phase 2A clinical trials testing MB22001, a proprietary microdosed LSD treatment for depression. The study, which involved self-administered, take-home microdoses, showed that patients experienced a 62.8% reduction in depressive symptoms three months after completing an 8-week course. The Phase ...
